RxDoctor Payments Data

Kelly Carden, MD

Sleep Medicine · Nashville, TNNPI 1811978737

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $19,875 of the $24,221 with a category attached, or 82.1%. Inspire Medical Systems, Inc. accounts for 91.7% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2021 at $11,011 and has fallen 94.6% since, to $592 in 2025. Among sleep medicine clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$24,221in general payments, 2019–2025

Across 67 payments — averaging $361.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Inspire Medical Systems, Inc.$22K
  • Jazz Pharmaceuticals Inc.$856
  • Harmony Biosciences LLC$803
  • Avadel CNS Pharmaceuticals, LLC$136
  • ZOLL Respicardia, Inc.$99
  • Axsome Therapeutics, Inc.$60
  • plus $48 from 1 others

What the payments were for

  • Consulting fees$19,87582%
  • Travel & lodging$1,3386%
  • Food & beverage$2,75911%
  • Education$2501%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$24,221 in reported general payments places this provider in the 95th percentile of 41 sleep medicine providers in Tennessee.

See all sleep medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$68,422
Medicare patients
498
Services billed
723

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XywavSodium,calcium,mag,pot Oxybate20$395,637
WakixPitolisant Hcl11$127,867
Armodafinil58$2,300
Modafinil25$1,270
Zolpidem Tartrate92$647
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine26$615
Trazodone Hcl36$282
Ropinirole Hcl17$200
Methadone Hcl21$181
Gabapentin39$149
Methylphenidate Hcl11$93
Lorazepam21$91
Doxepin Hcl16$77
Alprazolam17$68
Clonazepam12$25

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Harmony Biosciences LLCWakix$803$127,86711 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 41 sleep medicine providers in Tennessee.

Other sleep medicine in Nashville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →